|
"yen chia jui"的相關文件
顯示項目 21-30 / 77 (共8頁)
<< < 1 2 3 4 5 6 7 8 > >>
每頁顯示[10|25|50]項目
| 國立成功大學 |
2016-11-15 |
Second-line ramucirumab therapy for advanced hepatocellular carcinoma (REACH): an East Asian and non-East Asian subgroup analysis
|
Park, Joon Oh; Ryoo, Baek-Yeol; Yen, Chia-Jui; Kudo, Masatoshi; Yang, Ling; Abada, Paolo B.; Cheng, Rebecca; Orlando, Mauro; Zhu, Andrew X.; Okusaka, Takuji |
| 國立成功大學 |
2016-11 |
Angiopoietin-like protein 1 antagonizes MET receptor activity to repress sorafenib resistance and cancer stemness in hepatocellular carcinoma
|
Chen, Hsin-An; Kuo, Tsang-Chih; Tseng, Chi-Feng; Ma, Jui-Ti; Yang, Shu-Ting; Yen, Chia-Jui; Yang, Ching-Yao; Sung, Shian-Ying; Su, Jen-Liang |
| 國立成功大學 |
2016-10-25 |
A Comprehensive Analysis on the Association between Tobacco-Free Betel Quid and Risk of Head and Neck Cancer in Taiwanese Men
|
Wu, Yuan-Hua;Yen, Chia-Jui;Hsiao, Jenn-Ren;Ou, Chun-Yen;Huang, Jehn-Shyun;Wong, Tung-Yiu;Tsai, Sen-Tien;Huang, Cheng-Chih;Lee, Wei-Ting;Chen, Ken-Chung;Fang, Sheen-Yie;Wu, Jiunn-Liang;Hsueh, Wei-Ting;Lin, Forn-Chia;Yang, Ming-Wei;Chang, Jang-Yang;Liao, Hsiao-Chen;Wu, Shang-Yin;Lin, Chen-Lin;Wang, Yi-Hui;Weng, Ya-Ling;Yang, Han-Chien;Chen, Yu-Shan;Chang, Jeffrey S. |
| 國立成功大學 |
2016-10 |
Phase II Studies with Refametinib or Refametinib Plus Sorafenib in Patients with Mutant RAS Hepatocellular Carcinoma (HCC)
|
Llovet, Josep M.;Merle, Philippe;Weiss, Karl Heinz;Yau, Thomas;Ross, Paul;Mazzaferro, Vincenzo;Blanc, Jean-Frederic;Ma, Yuk T.;Yen, Chia Jui;Kocsis, Judit;Choo, Su Pin;Sukeepaisarnjaroen, Watana;Gerolami, Rene;Dufour, Jean -Francois;Gane, Edward J.;Ryoo, Baek-Yeol;Peck-Radosavljevic, Markus;Dao, Thong;Yeo, Winnie;Lamlertthon, Wisut;Thongsawat, Satawat;Teufel, Michael;Krissel, Heiko;Lim, Ho Yeong |
| 國立成功大學 |
2016-09 |
Allergy symptoms, serum total immunoglobulin E, and risk of head and neck cancer
|
Liao, Hsiao-Chen;Wu, Shang-Yin;Ou, Chun-Yen;Hsiao, Jenn-Ren;Huang, Jehn-Shyun;Tsai, Sen-Tien;Huang, Cheng-Chih;Wong, Tung-Yiu;Lee, Wei-Ting;Chen, Ken-Chung;Fang, Sheen-Yie;Wu, Jiunn-Liang;Huang, Tze-Ta;Wu, Yuan-Hua;Hsueh, Wei-Ting;Yen, Chia-Jui;Yang, Ming-Wei;Lin, Forn-Chia;Lai, Yu-Hsuan;Chang, Jang-Yang;Lin, Chen-Lin;Wang, Yi-Hui;Weng, Ya-Ling;Yang, Han-Chien;Chen, Yu-Shan;Chang, Jeffrey S. |
| 國立成功大學 |
2016-09 |
A Randomized Phase II Study of FOLFOX With or Without the MET Inhibitor Onartuzumab in Advanced Adenocarcinoma of the Stomach and Gastroesophageal Junction
|
Shah, Manish A.; Cho, Jae-Yong; Tan, Iain B.; Tebbutt, Niall C.; Yen, Chia-Jui; Kang, Alice; Shames, David S.; Bu, Lilian; Kang, Yoon-Koo |
| 國立成功大學 |
2016-08-30 |
Nuclear IKK alpha mediates microRNA-7/-103/107/21 inductions to downregulate maspin expression in response to HBx overexpression
|
Chen, Wen-Shu; Liu, Liang-Chih; Yen, Chia-Jui; Chen, Yun-Ju; Chen, Jhen-Yu; Ho, Chien-Yi; Liu, Shu-Hui; Chen, Ching-Chow; Huang, Wei-Chien |
| 國立成功大學 |
2016-08 |
Randomized phase II placebo controlled study of codrituzumab in previously treated patients with advanced hepatocellular carcinoma
|
Abou-Alfa, Ghassan K.;Puig, Oscar;Daniele, Bruno;Kudo, Masatoshi;Merle, Philippe;Park, Joong-Won;Ross, Paul;Peron, Jean-Marie;Ebert, Oliver;Chan, Stephen;Poon, Tung Ping;Colombo, Massimo;Okusaka, Takuji;Ryoo, Baek-Yeol;Minguez, Beatriz;Tanaka, Takayoshi;Ohtomo, Toshihiko;Ukrainskyj, Stacey;Boisserie, Frederic;Rutman, Olga;Chen, Ya-Chi;Xu, Chao;Shochat, Eliezer;Jukofsky, Lori;Reis, Bernhard;Chen, Gong;Di Laurenzio, Laura;Lee, Ray;Yen, Chia-Jui |
| 國立成功大學 |
2016-06-14 |
miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma
|
Yen, Chia-Sheng; Su, Zhi-Ru; Lee, Yi-Ping; Liu, I-Ting; Yen, Chia-Jui |
| 國立成功大學 |
2016-05-10 |
Resistance of ground glass hepatocytes to oral antivirals in chronic hepatitis B patients and implication for the development of hepatocellular carcinoma
|
Tsai, Hung-Wen; Lin, Yih-Jyh; Wu, Han-Chieh; Chang, Ting-Tsung; Wu, I-Chin; Cheng, Pin-Nan; Yen, Chia-Jui; Chan, Shih-Huang; Huang, Wenya; Su, Ih-Jen |
顯示項目 21-30 / 77 (共8頁)
<< < 1 2 3 4 5 6 7 8 > >>
每頁顯示[10|25|50]項目
|
